Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,386 | -2,534 | -57,466 | -54,886 | -47,981 |
| Depreciation Amortization | 3,266 | 1,641 | 6,839 | 5,255 | 3,650 |
| Income taxes - deferred | -1,542 | 0 | -223 | 13 | 13 |
| Accounts receivable | -7,620 | -4,262 | -14,930 | -13,779 | -7,978 |
| Accounts payable and accrued liabilities | -1,650 | -422 | 5,707 | 2,693 | 3,071 |
| Other Working Capital | -16,884 | -18,796 | -6,630 | -14,296 | -11,494 |
| Other Operating Activity | 35,207 | 17,538 | 61,077 | 50,787 | 31,494 |
| Operating Cash Flow | $17,163 | $-6,835 | $-5,626 | $-24,213 | $-29,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,744 | -10,554 | -2,575 | 1,307 | 8,562 |
| PPE Investments | -14,374 | -9,147 | -13,608 | -9,818 | -7,365 |
| Investing Cash Flow | $-41,118 | $-19,701 | $-16,183 | $-8,511 | $1,197 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -47 | -36 | -142 | -106 | -70 |
| Common Stock Issued | 1,822 | 1,154 | 2,978 | 2,224 | 1,872 |
| Other Financing Activity | -1,089 | -474 | -5,134 | -1,119 | -848 |
| Financing Cash Flow | $10,686 | $10,644 | $-2,298 | $999 | $954 |
| Beginning Cash Position | 98,841 | 98,841 | 122,948 | 122,948 | 122,948 |
| End Cash Position | 85,572 | 82,949 | 98,841 | 91,223 | 95,874 |
| Net Cash Flow | $-13,269 | $-15,892 | $-24,107 | $-31,725 | $-27,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,163 | -6,835 | -5,626 | -24,213 | -29,225 |
| Capital Expenditure | -14,381 | -9,152 | -13,621 | -9,828 | -7,373 |
| Free Cash Flow | 2,782 | -15,987 | -19,247 | -34,041 | -36,598 |